-
CSR Summary Not Yet Available
-
NCT00207740
-
Primary Citation
-
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameGolimumabProduct NameSIMPONI®Therapeutic AreaRespiratory Tract (Lung and Bronchial) DiseasesEnrollment309% Female56%% White88%
Product ClassAntirheumatic Agents - Biologic Response ModifiersSponsor Protocol NumberC0524T03Data PartnerJohnson & JohnsonCondition StudiedAsthmaMean/Median Age (Years)50.1
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available